Major pharmaceuticals and personal care products (PPCPs) in wastewater treatment plant and receiving water in Beijing, China, and associated ecological risks

Bulletin of Environmental Contamination and Toxicology

Volumn 92, Issue 6, 2014, Pages 655-661

  Dai, Guohua ^a   Huang, Jun ^a   Chen, Weiwei ^b   Wang, Bin ^a   Yu, Gang ^a   Deng, Shubo ^a  

^a TSINGHUA UNIVERSITY   (China)

^b Xiamen Urban Planning and Design Institute   (China)

Author keywords

Environmental risk assessment; PPCPs; Receiving water; Wastewater treatment plant

Indexed keywords

RISK ASSESSMENT; RISK PERCEPTION; SEWAGE PUMPING PLANTS; WATER TREATMENT PLANTS;

ENVIRONMENTAL CONCENTRATION; ENVIRONMENTAL RISK ASSESSMENT; N ,N-DIETHYL-M-TOLUAMIDE; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PPCPS; PREDICTED NO-EFFECT CONCENTRATIONS; RECEIVING WATERS; WASTEWATER TREATMENT PLANTS;

EFFLUENTS;

COSMETIC; DRUG; FRESH WATER;

ARTICLE; CHEMISTRY; CHINA; ENVIRONMENTAL MONITORING; SEWAGE; STATISTICS; WASTE WATER; WATER MANAGEMENT; WATER POLLUTANT; WATER SUPPLY;

CHINA; COSMETICS; ENVIRONMENTAL MONITORING; FRESH WATER; PHARMACEUTICAL PREPARATIONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER SUPPLY;

EID: 84904270152     PISSN: 00074861     EISSN: 14320800     Source Type: Journal    
DOI: 10.1007/s00128-014-1247-0     Document Type: Article

References (19)

1. Bendz D, Paxeus NA, Ginn TR, Logec FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J Hazard Mater 122:195-204
2. Chang H, Wan Y, Hu JY (2009) Determination and source apportion of five classes of steroid hormones in urban rivers. Environ Sci Technol 43:7691-7698
3. Costanz SD, Watkinson AJ, Murby EJ, Kolpin DW, Sandstrom MW (2007) Is there a risk associated with the insect repellent DEET (N, N-Diethyl-M- Toluamide) commonly found in aquatic environments? Sci Total Environ 384(1-3):214-220
4. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:907-938
5. EMEA (European Agency for the Evaluation of Medicinal Products) (2006) Guideline on the environmental risk assessment of medicinal products for human use CPMP/S WP/4447/00. http://www.ema.europa.eu/ema/. Accessed 13 May 3 2013
6. Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5-17
7. Heeb F, Singer H, Pernet-Coudrier B, Qi WX, Liu HJ, Longrée P, Müller B, Berg M (2012) Organic micropollutants in rivers downstream of the megacity beijing: sources and mass fluxes in a large-scale wastewater irrigation system. Environ Sci Technol 46:8680-8688
8. Hernando MD, Mezcua M, Fernandez-Alba AR, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69(2):334-342
9. Jelić A, Gros M, Petrović M, Ginebreda A, Barceló D (2012) Occurrence and elimination of pharmaceuticals during conventional wastewater treatment. In: Barceló D, Kostianoy AG (eds) Handbook of environmental chemistry, vol 19. Springer Berlin, Heidelberg, pp 1-24
10. Jia A, Wan Y, Xiao Y, Hu JY (2012) Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Res 46:387-394
11. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2009) The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 43:363-380
12. Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T et al (2006) Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Sci Total Environ 367: 544-558
13. Peng X, Wang Z, Kuang W, Tan J, Li K (2006) A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewater of two sewage treatment plants in Guangzhou, China. Sci Total Environ 371:314-322
14. Rosal R, Rodrìguez A, Perdigòn-Melòn JA, Petre A, Garcìa-Calvo E, Gòmez MJ et al (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44:578-588
15. Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ et al (2005) Human pharmaceuticals in us surface waters: a human health risk assessment. Regul Toxicol Pharmacol 42(3):296-312
16. Spongberg AL, Witter JD (2008) Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci Total Environ 397:148-157
17. Sui Q, Huang J, Deng SB, Chen WW, Yu G (2011) Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment. Environ Sci Technol 45:3341-3348
18. Tewari S, Jindal R, Kho YL, Eo S, Choi K (2013) Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks. Chemosphere 91:697-704
19. Verlicchi P, Al Aukidy M, Zambello E (2012) Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment: a review. Sci Total Environ 429:123-155